Recombinant Human Tyrosine-Protein Kinase Blk/BLK (C-6His)

Artikelnummer: ABI-32-8170
Artikelname: Recombinant Human Tyrosine-Protein Kinase Blk/BLK (C-6His)
Artikelnummer: ABI-32-8170
Hersteller Artikelnummer: 32-8170
Alternativnummer: ABI-32-8170-50UG
Hersteller: Abeomics
Kategorie: Proteine/Peptide
Source: E. coli. MW :58.7kD. Recombinant Human B Lymphocyte Kinase is produced by our E.coli expression system and the target gene encoding Gly2-Pro505 is expressed with a 6His tag at the C-terminus. Tyrosine-Protein Kinase Blk (BLK) contains one protein kinase domain, one SH2 domain and one SH3 domain. BLK is a non-receptor tyrosine kinase, which is involved in B-lymphocyte development, differentiation and signaling. B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors. Signaling through BLK plays an important role in transmitting signals through surface immunoglobulines and supports the pro-B to pre-B transition, as well as the signaling for growth arrest and apoptosis downstream of B-cell receptor. Defects in BLK are a cause of maturity-onset diabetes of the young type 11 (MODY11).
NCBI: 640
UniProt: P51451
Antibody Type: Recombinant Antibody
Application Verdünnung: Endotoxin : Less than 0.1 ng/µg (1 IEU/µg) as determined by LAL test.